United States of America et al v. JetBlue Airways Corporation and Spirit Airlines Inc.
The Court enjoined the proposed merger, ruling that such a merger would “lessen competition in violation of the Clayton Act.
In the Matter of Securus Technologies Inc. and Inmate Calling Solutions LLC
The parties abandoned their intent to merge after the DOJ opened its investigation into the acquisition.
FTC v. IQVIA Holdings Inc. et al.
The parties abandoned this merger shortly after the FTC’s preliminary injunction was granted.
Value Drug Company v. Takeda Pharmaceuticals U.S.A. Inc. et al.
Laurence Baker testified during a rare antitrust trial centering on the allegation that a brand manufacturer conspired with three generics to allocate the market for gout medication colchicine.
In re Novartis and Par Antitrust Litigation
Novartis reached settlements with plaintiffs in this reverse payment matter.
Secure Energy Services Inc./Tervita Corporation
The Competition Tribunal ruled in favor of the Canadian Competition Bureau's Commissioner of Competition in his challenge of Secure Energy’s acquisition of Tervita.
EC Investigation into Cloud Technology Company Merger
The European Commission cleared this merger after an investigation.
Amgen Inc.’s Acquisition of Horizon Therapeutics plc
The FTC approves Amgen’s $28B purchase of Horizon.
In re HIV Antitrust Litigation
The jury found in favor of the defense concluding, consistent with Dr. Saravia’s testimony, that the settlement contained no payment for delay.
Canadian Pacific Railway/Kansas City Southern
The Surface Transportation Board approved the $31 billion acquisition of Kansas City Southern by Canadian Pacific Railway.
How can we help you?
If you are looking for additional case experience examples, contact us.
